Showing results (181-190 of 435) with videos related to
Sort By:
Pageof 44
The American Journal of Surgical Pathology|December 6, 2005
Plasmablastic lymphoma in HIV-positive patients: an aggressive Epstein-Barr virus-associated extramedullary plasmacytic neoplasmHenry Y Dong, David T Scadden, Laurence de Leval, et al.Blood|April 19, 2003
Ex vivo targeting of p21Cip1/Waf1 permits relative expansion of human hematopoietic stem cellsSebastian Stier, Tao Cheng, Randolf Forkert, et al.The Journal of Bone and Joint Surgery. British Volume|April 28, 2007
Embolic phenomena during computer-assisted and conventional total knee replacementJ S Church, J E Scadden, R R Gupta, et al.Journal of Virology|June 1, 1990
Human immunodeficiency virus does not induce interleukin-1, interleukin-6, or tumor necrosis factor in mononuclear cellsJ M Molina, D T Scadden, C Amirault, et al.Biorxiv : the Preprint Server for Biology|July 18, 2023
Histone deacetylation and cytosine methylation compartmentalize heterochromatic regions in the genome organization of Neurospora crassaAshley W Scadden, Alayne S Graybill, Clayton Hull-Crew, et al.Blood|July 15, 1990
Human immunodeficiency virus infection of human bone marrow stromal fibroblastsD T Scadden, M Zeira, A Woon, et al.European Journal of Immunology|March 19, 2013
Influenza, but not HIV-specific CTL epitopes, elicits delayed-type hypersensitivity (DTH) reactions in HIV-infected patientsMarta Ruiz-Riol, Beatriz Mothe, Rajesh T Gandhi, et al.Cell Death & Disease|July 6, 2013
The purinergic P2Y14 receptor axis is a molecular determinant for organism survival under in utero radiation toxicityS H Kook, J S Cho, A Morrison, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1991
Granulocyte-macrophage colony-stimulating factor mitigates the neutropenia of combined interferon alfa and zidovudine treatment of acquired immune deficiency syndrome-associated Kaposi's sarcomaD T Scadden, H A Bering, J D Levine, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 16, 2004
Angiogenesis inhibitor IM862 is ineffective against AIDS-Kaposi's sarcoma in a phase III trial, but demonstrates sustained, potent effect of highly active antiretroviral therapy: from the AIDS Malignancy Consortium and IM862 Study TeamAriela Noy, David T Scadden, Jeannette Lee, et al.Pageof 44